Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3018]
News [6108]
Articles [120]
Editorials [18]
Conferences [179]
elearning [32]
Navigating through the changing treatment landscape of advanced prostate cancer
Prof Heather Payne, Dr Luis Martinez-Piñeiro, Prof Woet Gianotten, Prof Álvaro...
Navigating through the changing treatment landscape of advanced prostate cancer ( Prof Heather Payne, Dr Luis Martinez-Piñeiro, Prof Woet Gianotten, Prof Álvaro Pinto and Prof Anders Bjartell )
2 May 2018
Editor's Choice for April 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for April 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
27 Apr 2018
Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer
Dr Arjun Balar - NYU Langone Medical Center, New York, USA
Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer ( Dr Arjun Balar - NYU Langone Medical Center, New York, USA )
25 Apr 2018
Safety indications in mouse models treated with full doses of MEK inhibitors...
Dr Carmine Fedele - Laura and Isaac Perlmutter Cancer Center at New York...
Safety indications in mouse models treated with full doses of MEK inhibitors and SHP099 ( Dr Carmine Fedele - Laura and Isaac Perlmutter Cancer Center at New York University Langone Medical, New York, USA )
25 Apr 2018
A variety of approaches to measure the efficacy of PARP inhibitors
Dr Elisabetta Leo - AstraZeneca, Cambridge, UK
A variety of approaches to measure the efficacy of PARP inhibitors ( Dr Elisabetta Leo - AstraZeneca, Cambridge, UK )
25 Apr 2018
Development and clinical indications of PARP inhibitors
Dr Mark O'Connor - AstraZeneca, Cambridge, UK
Development and clinical indications of PARP inhibitors ( Dr Mark O'Connor - AstraZeneca, Cambridge, UK )
25 Apr 2018
AKT inhibitors in research and application
Dr Brian Schwartz - ArQule, Burlington, USA
AKT inhibitors in research and application ( Dr Brian Schwartz - ArQule, Burlington, USA )
25 Apr 2018
Increasing diversity through the NCI SBIR development centre
Dr Christie Canaria - National Cancer Institute, Rockville, USA
Increasing diversity through the NCI SBIR development centre ( Dr Christie Canaria - National Cancer Institute, Rockville, USA )
25 Apr 2018
Clinical development and economic prospects of CAR T cell immunotherapies
Dr Bob Velamehr - Fate Therapeutics, La Jolla, USA
Clinical development and economic prospects of CAR T cell immunotherapies ( Dr Bob Velamehr - Fate Therapeutics, La Jolla, USA )
25 Apr 2018
Response and safety profile of neoadjuvant nivolumab for resectable lung cancer
Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA
Response and safety profile of neoadjuvant nivolumab for resectable lung cancer ( Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA )
25 Apr 2018
Doubled survival in metastatic lung cancer with combination therapy
Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Doubled survival in metastatic lung cancer with combination therapy ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018
Combined immuno-chemotherapy improves survival and responses in metastatic lung...
Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation